Grants and Contributions

The CIHR Institute of Genetics (CIHR-IG) will provide funding for applications that are determined to be relevant to its mandate:

• CIHR-IG supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries.

The specific objectives of this funding opportunity are:

• Catalyze community-led research planning and development activities in Canada that ensure the inclusion and meaningful representation of people experiencing climate change-related health impacts;
• Foster meaningful and equitable partnerships between communities in Canada impacted by climate change and researchers to advance research focused on community-driven priorities;
• Engage impacted communities to strengthen capacity for knowledge mobilization; and/or,
• Better position teams of researchers and community partners to develop applications for future funding in support of co-developed CBR climate change research and knowledge mobilization projects/programs.

The specific objectives of this funding opportunity are:

• Catalyze community-led research planning and development activities in Canada that ensure the inclusion and meaningful representation of people experiencing climate change-related health impacts;
• Foster meaningful and equitable partnerships between communities in Canada impacted by climate change and researchers to advance research focused on community-driven priorities;
• Engage impacted communities to strengthen capacity for knowledge mobilization; and/or,
• Better position teams of researchers and community partners to develop applications for future funding in support of co-developed CBR climate change research and knowledge mobilization projects/programs.

The specific objectives of this funding opportunity are:

• Catalyze community-led research planning and development activities in Canada that ensure the inclusion and meaningful representation of people experiencing climate change-related health impacts;
• Foster meaningful and equitable partnerships between communities in Canada impacted by climate change and researchers to advance research focused on community-driven priorities;
• Engage impacted communities to strengthen capacity for knowledge mobilization; and/or,
• Better position teams of researchers and community partners to develop applications for future funding in support of co-developed CBR climate change research and knowledge mobilization projects/programs.

The specific objectives of this funding opportunity are:

• Catalyze community-led research planning and development activities in Canada that ensure the inclusion and meaningful representation of people experiencing climate change-related health impacts;
• Foster meaningful and equitable partnerships between communities in Canada impacted by climate change and researchers to advance research focused on community-driven priorities;
• Engage impacted communities to strengthen capacity for knowledge mobilization; and/or,
• Better position teams of researchers and community partners to develop applications for future funding in support of co-developed CBR climate change research and knowledge mobilization projects/programs.

This prize was established to honour the past Scientific Director of the CIHR Institute of Aging, Yves Joanette, for his outstanding contributions to the area of research on aging in Canada and Internationally.

This prize will be given annually to the highest-ranking funded project in the Project Grant competition that is relevant to one of the Institute of Aging’s areas as outlined in the CIHR IA Strategic Plan 2023-2028: Reframing Aging Empowering Older Adults.

This prize is a supplemental grant to support research and has to be used according to the CIHR Grants and Awards Guide. The prize is not a personal award and is non-renewable.

The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

This PA will fund Breast Cancer research in the following priority areas:

• General Breast Cancer Research
o research that supports CIHR-ICR’s mandate in the area of Breast Cancer
• Breast Cancer Prevention and/or Early Detection of Breast Cancer
o research that prevents the onset of breast cancer (lowers cancer risk) and/or reduces the severity of the disease through early detection when it is at its most treatable.
• Breast Cancer Survivorship
o research that mitigates the challenges experienced along the breast cancer survivorship journey and improves the health outcomes for breast cancer survivors of all ages from the time of their cancer diagnosis until the time of their death or entry into end-of-life care.
o specifically in the areas of:
¿ Late & Long-Term Effects
¿ Survivors’ Experiences & Outcomes
¿ Models of Care
o This PA will not fund research focused on improving end-of-life care.

• This PA supports research that creates new knowledge and/or moves it into practice in the health system, communities, workplaces, and in the daily lives of Canadians.

The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

This PA will fund Breast Cancer research in the following priority areas:

• General Breast Cancer Research
o research that supports CIHR-ICR’s mandate in the area of Breast Cancer
• Breast Cancer Prevention and/or Early Detection of Breast Cancer
o research that prevents the onset of breast cancer (lowers cancer risk) and/or reduces the severity of the disease through early detection when it is at its most treatable.
• Breast Cancer Survivorship
o research that mitigates the challenges experienced along the breast cancer survivorship journey and improves the health outcomes for breast cancer survivors of all ages from the time of their cancer diagnosis until the time of their death or entry into end-of-life care.
o specifically in the areas of:
¿ Late & Long-Term Effects
¿ Survivors’ Experiences & Outcomes
¿ Models of Care
o This PA will not fund research focused on improving end-of-life care.

• This PA supports research that creates new knowledge and/or moves it into practice in the health system, communities, workplaces, and in the daily lives of Canadians.

The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

This PA will fund Breast Cancer research in the following priority areas:

• General Breast Cancer Research
o research that supports CIHR-ICR’s mandate in the area of Breast Cancer
• Breast Cancer Prevention and/or Early Detection of Breast Cancer
o research that prevents the onset of breast cancer (lowers cancer risk) and/or reduces the severity of the disease through early detection when it is at its most treatable.
• Breast Cancer Survivorship
o research that mitigates the challenges experienced along the breast cancer survivorship journey and improves the health outcomes for breast cancer survivors of all ages from the time of their cancer diagnosis until the time of their death or entry into end-of-life care.
o specifically in the areas of:
¿ Late & Long-Term Effects
¿ Survivors’ Experiences & Outcomes
¿ Models of Care
o This PA will not fund research focused on improving end-of-life care.

• This PA supports research that creates new knowledge and/or moves it into practice in the health system, communities, workplaces, and in the daily lives of Canadians.

The specific objective of this funding opportunity is to:

• Catalyze and support research efforts of Canadian researchers to use the available CLSA data in order to better understand how biological, medical, psychological, social, lifestyle and/or economic aspects of people’s lives have an impact on both maintaining health and the development of disease and disability as people age.